Show Notes
China has become an increasingly important part of global clinical development, with sponsors considering the region earlier than ever before as part of their broader development strategies.
In this episode, Meredith Landry, Managing Editor of Citeline's Custom Content, speaks with Catherine Xu, Senior Operations Manager at Novotech, about the factors reshaping China's role in global clinical development. Drawing on her extensive experience supporting international clinical programmes, Catherine shares insights into the changing perceptions of China, the evolving regulatory landscape, and what sponsors should consider when planning global development strategies.
In this conversation, they explore:
• Why more sponsors are rethinking China's role in global clinical development
• The opportunities and misconceptions shaping today's development strategies
• What sponsors should consider when incorporating China into global programmes
• How China's role in global clinical development could evolve over the coming years
More from Scrip Podcasts
Ahead of the awards presentation on Dec 2, the Scrip Awards podcast speaks to Mathai Mammen, CEO of Parabilis, one of the shortlisted companies for Biotech of The Year.
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年10月16日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。
Join us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five Must-Know Things.
Join us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five Must-Know Things.
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2026年10月9日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本周内容包括：中国带来的竞争威胁；第三季度并购活动降温；新型肺炎球菌疫苗竞争者；西班牙生物技术公司的战略；以及盐野义制药20亿美元的收购案。